▶ 調査レポート

世界の遺伝性疾患薬市場2019

• 英文タイトル:Global Genetic Disorders Drug Sales Market Report 2019

QYResearchが調査・発行した産業分析レポートです。世界の遺伝性疾患薬市場2019 / Global Genetic Disorders Drug Sales Market Report 2019 / QYR9N1279資料のイメージです。• レポートコード:QYR9N1279
• 出版社/出版日:QYResearch / 2019年6月10日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、遺伝性疾患薬の世界市場について調査・分析し、遺伝性疾患薬のメーカー別販売量、市場シェア分析、種類別販売分析(嚢胞性線維症(CF)、デュシェンヌ型筋ジストロフィー(DMD)、リソソーム蓄積症(LSD)、発作性夜間血色素尿症(PNH))、用途別販売分析(診療所、病院)、地域別販売分析(米国、ヨーロッパ、中国、日本、東南アジア、インド)、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします。

・遺伝性疾患薬市場概要
・遺伝性疾患薬のメーカー別販売量・メーカー別シェア
・遺伝性疾患薬の種類別販売量(嚢胞性線維症(CF)、デュシェンヌ型筋ジストロフィー(DMD)、リソソーム蓄積症(LSD)、発作性夜間血色素尿症(PNH))
・遺伝性疾患薬の用途別販売量(診療所、病院)
・遺伝性疾患薬の地域別販売量・市場シェア
・遺伝性疾患薬の米国市場規模(2014年-2019年)
・遺伝性疾患薬のヨーロッパ市場規模(2014年-2019年)
・遺伝性疾患薬の中国市場規模(2014年-2019年)
・遺伝性疾患薬の日本市場規模(2014年-2019年)
・遺伝性疾患薬の東南アジア市場規模(2014年-2019年)
・遺伝性疾患薬のインド市場規模(2014年-2019年)
・遺伝性疾患薬メーカー分析(企業概要、製品概要、販売量、売上、価格等)
・遺伝性疾患薬のコスト分析
・遺伝性疾患薬販売チャネル、流通業者、顧客
・遺伝性疾患薬の世界市場動向・機会・成長要因・課題
・遺伝性疾患薬の種類別世界市場予測(嚢胞性線維症(CF)、デュシェンヌ型筋ジストロフィー(DMD)、リソソーム蓄積症(LSD)、発作性夜間血色素尿症(PNH))
・遺伝性疾患薬の用途別世界市場予測(診療所、病院)
・遺伝性疾患薬の米国市場予測(2019年-2025年)
・遺伝性疾患薬のヨーロッパ市場予測(2019年-2025年)
・遺伝性疾患薬の中国市場予測(2019年-2025年)
・遺伝性疾患薬の日本市場予測(2019年-2025年)
・遺伝性疾患薬の東南アジア市場予測(2019年-2025年)
・遺伝性疾患薬のインド市場予測(2019年-2025年)
...

The global Genetic Disorders Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report studies the global Genetic Disorders Drug market status and forecast, categorizes the global Genetic Disorders Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
Sanofi
Vertex
Shire
Amgen
GW Pharmaceuticals
Pfizer
BioMarin
Sarepta

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
Cystic Fibrosis (CF)
Duchenne Muscular Dystrophy (DMD)
Lysosomal Storage Disease (LSD)
Paroxysmal Nocturnal Hemoglobinuria (PNH)

Segment by Application
Clinic
Hospital

レポート目次

Table of Contents

Global Genetic Disorders Drug Sales Market Report 2019
1 Genetic Disorders Drug Market Overview
1.1 Genetic Disorders DrugProduct Overview
1.2 Genetic Disorders Drug Segment by Type
1.2.1 Global Genetic Disorders Drug Sales Comparison by Types (2014-2025)
1.2.2 Cystic Fibrosis (CF)
1.2.3 Duchenne Muscular Dystrophy (DMD)
1.2.4 Lysosomal Storage Disease (LSD)
1.2.5 Paroxysmal Nocturnal Hemoglobinuria (PNH)
1.3 Genetic Disorders Drug Segment by Application
1.3.1 Global Genetic Disorders Drug Sales Comparison by Application (2014-2025)
1.3.1 Clinic
1.3.2 Hospital
1.4 Genetic Disorders Drug Market by Region
1.4.1 Global Genetic Disorders Drug Revenue Comparison by Region (2014-2025)
1.4.2 United States Genetic Disorders Drug Status and Prospect (2014-2025)
1.4.3 Europe Genetic Disorders Drug Status and Prospect (2014-2025)
1.4.4 China Genetic Disorders Drug Status and Prospect (2014-2025)
1.4.5 Japan Genetic Disorders Drug Status and Prospect (2014-2025)
1.4.6 Southeast Asia Genetic Disorders Drug Status and Prospect (2014-2025)
1.4.7 India Genetic Disorders Drug Status and Prospect (2014-2025)
1.5 Global Genetic Disorders Drug Sales and Revenue (2014-2025)
1.5.1 Global Genetic Disorders Drug Sales and Growth Rate (2014-2025)
1.5.2 Global Genetic Disorders Drug Revenue and Growth Rate (2014-2025)

2 Genetic Disorders Drug by Company, Region, Type and Application
2.1 Global Genetic Disorders Drug Market Competition by Companies
2.1.1 Global Genetic Disorders Drug Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Genetic Disorders Drug Revenue Market Share by Company (2014-2019)
2.2 Global Genetic Disorders Drug Sales and Revenue by Region
2.2.1 Global Genetic Disorders Drug Sales Market Share by Region (2014-2019)
2.2.2 Global Genetic Disorders Drug Revenue Market Share by Region (2014-2019)
2.3 Global Genetic Disorders Drug Sales and Revenue by Type
2.3.1 Global Genetic Disorders Drug Sales Market Share by Type (2014-2019)
2.3.2 Global Genetic Disorders Drug Revenue Market Share by Type (2014-2019)
2.4 Global Genetic Disorders Drug Sales by Application

3 United States Genetic Disorders Drug Sales, Revenue and Price
3.1 United States Genetic Disorders Drug Sales and Revenue (2014-2019)
3.1.1 United States Genetic Disorders Drug Sales Growth Rate (2014-2019)
3.1.2 United States Genetic Disorders Drug Revenue Growth Rate (2014-2019)
3.1.3 United States Genetic Disorders Drug Price Trend (2014-2019)
3.2 United States Genetic Disorders Drug Sales Market Share by Company
3.3 United States Genetic Disorders Drug Sales Market Share by Type
3.4 United States Genetic Disorders Drug Sales Market Share by Application

4 Europe Genetic Disorders Drug Sales, Revenue and Price
4.1 Europe Genetic Disorders Drug Sales and Value (2014-2019)
4.1.1 Europe Genetic Disorders Drug Sales Growth Rate (2014-2019)
4.1.2 Europe Genetic Disorders Drug Revenue Growth Rate (2014-2019)
4.1.3 Europe Genetic Disorders Drug Price Trend (2014-2019)
4.2 Europe Genetic Disorders Drug Sales Market Share by Company
4.3 Europe Genetic Disorders Drug Sales Market Share by Type
4.4 Europe Genetic Disorders Drug Sales Market Share by Application

5 China Genetic Disorders Drug Sales, Revenue and Price
5.1 China Genetic Disorders Drug Sales and Revenue (2014-2019)
5.1.1 China Genetic Disorders Drug Sales Growth Rate (2014-2019)
5.1.2 China Genetic Disorders Drug Revenue Growth Rate (2014-2019)
5.1.3 China Genetic Disorders Drug Price Trend (2014-2019)
5.2 China Genetic Disorders Drug Sales Market Share by Company
5.3 China Genetic Disorders Drug Sales Market Share by Type
5.4 China Genetic Disorders Drug Sales Market Share by Application

6 Japan Genetic Disorders Drug Sales, Revenue and Price
6.1 Japan Genetic Disorders Drug Sales and Value (2014-2019)
6.1.1 Japan Genetic Disorders Drug Sales Growth Rate (2014-2019)
6.1.2 Japan Genetic Disorders Drug Revenue Growth Rate (2014-2019)
6.1.3 Japan Genetic Disorders Drug Price Trend (2014-2019)
6.2 Japan Genetic Disorders Drug Sales Market Share by Company
6.3 Japan Genetic Disorders Drug Sales Market Share by Type
6.4 Japan Genetic Disorders Drug Sales Market Share by Application

7 Southeast Asia Genetic Disorders Drug Sales, Revenue and Price
7.1 Southeast Asia Genetic Disorders Drug Sales and Value (2014-2019)
7.1.1 Southeast Asia Genetic Disorders Drug Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Genetic Disorders Drug Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Genetic Disorders Drug Price Trend (2014-2019)
7.2 Southeast Asia Genetic Disorders Drug Sales Market Share by Company
7.3 Southeast Asia Genetic Disorders Drug Sales Market Share by Type
7.4 Southeast Asia Genetic Disorders Drug Sales Market Share by Application

8 India Genetic Disorders Drug Sales, Revenue and Price
8.1 India Genetic Disorders Drug Sales and Value (2014-2019)
8.1.1 India Genetic Disorders Drug Sales Growth Rate (2014-2019)
8.1.2 India Genetic Disorders Drug Revenue Growth Rate (2014-2019)
8.1.3 India Genetic Disorders Drug Price Trend (2014-2019)
8.2 India Genetic Disorders Drug Sales Market Share by Company
8.3 India Genetic Disorders Drug Sales Market Share by Type
8.4 India Genetic Disorders Drug Sales Market Share by Application

9 Company Profiles and Key Figures in Genetic Disorders Drug Business
9.1 Sanofi
9.1.1 Sanofi Genetic Disorders Drug Production Sites and Area Served
9.1.2 Genetic Disorders Drug Specification and Application
9.1.3 Sanofi Genetic Disorders Drug Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 Vertex
9.2.1 Vertex Genetic Disorders Drug Production Sites and Area Served
9.2.2 Genetic Disorders Drug Specification and Application
9.2.3 Vertex Genetic Disorders Drug Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 Shire
9.3.1 Shire Genetic Disorders Drug Production Sites and Area Served
9.3.2 Genetic Disorders Drug Specification and Application
9.3.3 Shire Genetic Disorders Drug Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 Amgen
9.4.1 Amgen Genetic Disorders Drug Production Sites and Area Served
9.4.2 Genetic Disorders Drug Specification and Application
9.4.3 Amgen Genetic Disorders Drug Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
9.5 GW Pharmaceuticals
9.5.1 GW Pharmaceuticals Genetic Disorders Drug Production Sites and Area Served
9.5.2 Genetic Disorders Drug Specification and Application
9.5.3 GW Pharmaceuticals Genetic Disorders Drug Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business and Markets Served
9.6 Pfizer
9.6.1 Pfizer Genetic Disorders Drug Production Sites and Area Served
9.6.2 Genetic Disorders Drug Specification and Application
9.6.3 Pfizer Genetic Disorders Drug Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business and Markets Served
9.7 BioMarin
9.7.1 BioMarin Production Sites and Area Served
9.7.2 Genetic Disorders Drug Specification and Application
9.7.3 BioMarin Genetic Disorders Drug Sales, Revenue, Price and Gross Margin (2014-2019)
9.7.4 Main Business and Markets Served
9.8 Sarepta
9.8.1 Sarepta Genetic Disorders Drug Production Sites and Area Served
9.8.2 Genetic Disorders Drug Specification and Application
9.8.3 Sarepta Genetic Disorders Drug Sales, Revenue, Price and Gross Margin (2014-2019)
9.8.4 Main Business and Markets Served

10 Genetic Disorders Drug Maufacturing Cost Analysis
10.1 Genetic Disorders Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Genetic Disorders Drug
10.4 Genetic Disorders Drug Industrial Chain Analysis

11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Genetic Disorders Drug Distributors List
11.3 Genetic Disorders Drug Customers

12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors

13 Genetic Disorders Drug Market Forecast
13.1 Global Genetic Disorders Drug Sales, Revenue and Price Forecast
13.1.1 Global Genetic Disorders Drug Sales Growth Forecast (2019-2025)
13.1.2 Global Genetic Disorders Drug Revenue Growth Forecast (2019-2025)
13.1.3 Global Genetic Disorders Drug Price Trend Forecast (2019-2025)
13.2 Global Genetic Disorders Drug Forecast by Region
13.2.1 Global Genetic Disorders Drug Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Genetic Disorders Drug Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Genetic Disorders Drug Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Genetic Disorders Drug Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Genetic Disorders Drug Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Genetic Disorders Drug Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Genetic Disorders Drug Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Genetic Disorders Drug Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Genetic Disorders Drug Forecast by Type
13.3.1 Global Genetic Disorders Drug Sales Forecast by Type (2019-2025)
13.3.2 Global Genetic Disorders Drug Revenue Forecast by Type (2019-2025)
13.3.3 Global Genetic Disorders Drug Price Forecast by Type (2019-2025)
13.4 Global Genetic Disorders Drug Forecast by Application

14 Research Findings and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

List of Tables and Figures

Market Breakdown by Region: Genetic Disorders Drug Sales (K Units) and Value (Revenue: Million US$)
Market Breakdown by Type: Genetic Disorders Drug Sales (K Units) and Revenue (Million US$)
Market Breakdown by Application: Genetic Disorders Drug Sales (Jan)
Figure Genetic Disorders Drug Product Picture
Table Global Genetic Disorders Drug Sales (K Units) Growth Rate by Types (2014-2025)
Figure Global Genetic Disorders Drug Sales Market Share by Types in 2018
Figure Cystic Fibrosis (CF) Product Picture
Figure Duchenne Muscular Dystrophy (DMD) Product Picture
Figure Lysosomal Storage Disease (LSD) Product Picture
Figure Paroxysmal Nocturnal Hemoglobinuria (PNH) Product Picture
Table Global Genetic Disorders Drug Sales (K Units) Comparison by Application (2014-2025)
Figure Global Sales Market Share of Genetic Disorders Drug by Application in 2018
Figure Clinic Examples
Figure Hospital Examples
Table Global Market Genetic Disorders Drug Revenue (Million USD) Comparison by Region 2014-2025
Figure United States Genetic Disorders Drug Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Genetic Disorders Drug Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Genetic Disorders Drug Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Genetic Disorders Drug Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Genetic Disorders Drug Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Genetic Disorders Drug Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Genetic Disorders Drug Sales (K Units) Growth Rate (2014-2025)
Figure Global Genetic Disorders Drug Revenue (Million USD) Growth Rate (2014-2025)
Table Global Genetic Disorders Drug Sales (K Units) of Key Companies (2014-2019)
Figure Global Genetic Disorders Drug Sales by Company in 2018
Table Global Genetic Disorders Drug Sales Share by Company (2014-2019)
Figure Global Genetic Disorders Drug Sales Share by Company in 2018
Table Global Genetic Disorders Drug Revenue (Million USD) by Company (2014-2019)
Figure Global Genetic Disorders Drug Revenue (Million USD) by Company in 2018
Table Global Genetic Disorders Drug Revenue Share by Company (2014-2019)
Figure Global Genetic Disorders Drug Revenue Share by Company in 2018
Table Global Genetic Disorders Drug Sales (K Units) Market Share by Region (2014-2019)
Table Global Genetic Disorders Drug Sales Share by Region (2014-2019)
Figure Global Genetic Disorders Drug Sales Share by Region in 2018
Table Global Genetic Disorders Drug Revenue (Million USD) Market Share by Region (2014-2019)
Table Global Genetic Disorders Drug Revenue Share by Region (2014-2019)
Figure Global Genetic Disorders Drug Revenue Market Share by Region In 2018
Table Global Genetic Disorders Drug Sales (K Units) by Type (2014-2019)
Table Global Genetic Disorders Drug Sales Share by Type (2014-2019)
Figure Global Genetic Disorders Drug Sales Growth Rate by Type in 2018
Table Global Genetic Disorders Drug Revenue (Million USD) Market Share by Type (2014-2019)
Table Global Genetic Disorders Drug Revenue Share by Type (2014-2019)
Figure Global Genetic Disorders Drug Revenue Growth Rate by Type in 2018
Table Global Genetic Disorders Drug Sales Market Share by Application (2014-2019)
Table Global Genetic Disorders Drug Sales Share by Application (2014-2019)
Figure Global Genetic Disorders Drug Sales Market Share by Application in 2018
Figure United States Genetic Disorders Drug Sales (K Units) and Growth Rate (2014-2019)
Figure United States Genetic Disorders Drug Revenue (Million USD) and Growth Rate (2014-2019)
Figure United States Genetic Disorders Drug Price (USD/Unit) Trend (2014-2019)
Table United States Genetic Disorders Drug Sales (K Units) by Company (2014-2019)
Table United States Genetic Disorders Drug Sales Market Share by Company (2014-2019)
Figure United States Genetic Disorders Drug Sales Market Share by Company in 2018
Table United States Genetic Disorders Drug Sales (K Units) by Type (2014-2019)
Table United States Genetic Disorders Drug Sales Market Share by Type (2014-2019)
Figure United States Genetic Disorders Drug Sales Market Share by Type in 2018
Table United States Genetic Disorders Drug Sales (K Units) by Application (2014-2019)
Table United States Genetic Disorders Drug Sales Market Share by Application (2014-2019)
Figure United States Genetic Disorders Drug Sales Market Share by Application in 2018
Figure Europe Genetic Disorders Drug Sales (K Units) and Growth Rate (2014-2019)
Figure Europe Genetic Disorders Drug Revenue (Million USD) and Growth Rate (2014-2019)
Figure Europe Genetic Disorders Drug Price (USD/Unit) Trend (2014-2019)
Table Europe Genetic Disorders Drug Sales (K Units) by Company (2014-2019)
Table Europe Genetic Disorders Drug Sales Market Share by Company (2014-2019)
Figure Europe Genetic Disorders Drug Sales Market Share by Company in 2018
Table Europe Genetic Disorders Drug Sales (K Units) by Type (2014-2019)
Table Europe Genetic Disorders Drug Sales Market Share by Type (2014-2019)
Figure Europe Genetic Disorders Drug Sales Market Share by Type in 2018
Table Europe Genetic Disorders Drug Sales (K Units) by Application (2014-2019)
Table Europe Genetic Disorders Drug Sales Market Share by Application (2014-2019)
Figure Europe Genetic Disorders Drug Sales Market Share by Application in 2018
Figure China Genetic Disorders Drug Sales (K Units) and Growth Rate (2014-2019)
Figure China Genetic Disorders Drug Revenue (Million USD) and Growth Rate (2014-2019)
Figure China Genetic Disorders Drug Price (USD/Unit) Trend (2014-2019)
Table China Genetic Disorders Drug Sales (K Units) by Company (2014-2019)
Table China Genetic Disorders Drug Sales Market Share by Company (2014-2019)
Figure China Genetic Disorders Drug Sales Market Share by Company in 2018
Table China Genetic Disorders Drug Sales (K Units) by Type (2014-2019)
Table China Genetic Disorders Drug Sales Market Share by Type (2014-2019)
Figure China Genetic Disorders Drug Sales Market Share by Type in 2018
Table China Genetic Disorders Drug Sales (K Units) by Application (2014-2019)
Table China Genetic Disorders Drug Sales Market Share by Application (2014-2019)
Figure China Genetic Disorders Drug Sales Market Share by Application in 2018
Figure Japan Genetic Disorders Drug Sales (K Units) and Growth Rate (2014-2019)
Figure Japan Genetic Disorders Drug Revenue (Million USD) and Growth Rate (2014-2019)
Figure Japan Genetic Disorders Drug Price (USD/Unit) Trend (2014-2019)
Table Japan Genetic Disorders Drug Sales (K Units) by Company (2014-2019)
Table Japan Genetic Disorders Drug Sales Market Share by Company (2014-2019)
Figure Japan Genetic Disorders Drug Sales Market Share by Company in 2018
Table Japan Genetic Disorders Drug Sales (K Units) by Type (2014-2019)
Table Japan Genetic Disorders Drug Sales Market Share by Type (2014-2019)
Figure Japan Genetic Disorders Drug Sales Market Share by Type in 2018
Table Japan Genetic Disorders Drug Sales (K Units) by Application (2014-2019)
Table Japan Genetic Disorders Drug Sales Market Share by Application (2014-2019)
Figure Japan Genetic Disorders Drug Sales Market Share by Application in 2018
Figure Southeast Asia Genetic Disorders Drug Sales (K Units) and Growth Rate (2014-2019)
Figure Southeast Asia Genetic Disorders Drug Revenue (Million USD) and Growth Rate (2014-2019)
Figure Southeast Asia Genetic Disorders Drug Price (USD/Unit) Trend (2014-2019)
Table Southeast Asia Genetic Disorders Drug Sales (K Units) by Company (2014-2019)
Table Southeast Asia Genetic Disorders Drug Sales Market Share by Company (2014-2019)
Figure Southeast Asia Genetic Disorders Drug Sales Market Share by Company in 2018
Table Southeast Asia Genetic Disorders Drug Sales (K Units) by Type (2014-2019)
Table Southeast Asia Genetic Disorders Drug Sales Market Share by Type (2014-2019)
Figure Southeast Asia Genetic Disorders Drug Sales Market Share by Type in 2018
Table Southeast Asia Genetic Disorders Drug Sales (K Units) by Application (2014-2019)
Table Southeast Asia Genetic Disorders Drug Sales Market Share by Application (2014-2019)
Figure Southeast Asia Genetic Disorders Drug Sales Market Share by Application in 2018
Figure India Genetic Disorders Drug Sales (K Units) and Growth Rate (2014-2019)
Figure India Genetic Disorders Drug Revenue (Million USD) and Growth Rate (2014-2019)
Figure India Genetic Disorders Drug Price (USD/Unit) Trend (2014-2019)
Table India Genetic Disorders Drug Sales (K Units) by Company (2014-2019)
Table India Genetic Disorders Drug Sales Market Share by Company (2014-2019)
Figure India Genetic Disorders Drug Sales Market Share by Company in 2018
Table India Genetic Disorders Drug Sales (K Units) by Type (2014-2019)
Table India Genetic Disorders Drug Sales Market Share by Type (2014-2019)
Figure India Genetic Disorders Drug Sales Market Share by Type in 2018
Table India Genetic Disorders Drug Sales (K Units) by Application (2014-2019)
Table India Genetic Disorders Drug Sales Market Share by Application (2014-2019)
Figure India Genetic Disorders Drug Sales Market Share by Application in 2018
Table Sanofi Genetic Disorders Drug Production Sites and Area Served
Table Sanofi Genetic Disorders Drug Specification and Application
Table Sanofi Genetic Disorders Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Sanofi Genetic Disorders Drug Sales Growth Rate (2014-2019)
Figure Sanofi Genetic Disorders Drug Revenue Share in International Market (2014-2019)
Figure Sanofi Genetic Disorders Drug Main Business and Markets Served
Table Vertex Genetic Disorders Drug Production Sites and Area Served
Table Vertex Genetic Disorders Drug Specification and Application
Table Vertex Genetic Disorders Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Vertex Genetic Disorders Drug Sales Growth Rate (2014-2019)
Figure Vertex Genetic Disorders Drug Revenue Share in International Market (2014-2019)
Figure Vertex Genetic Disorders Drug Main Business and Markets Served
Table Shire Genetic Disorders Drug Production Sites and Area Served
Table Shire Genetic Disorders Drug Specification and Application
Table Shire Genetic Disorders Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Shire Genetic Disorders Drug Sales Growth Rate (2014-2019)
Figure Shire Genetic Disorders Drug Revenue Share in International Market (2014-2019)
Figure Shire Genetic Disorders Drug Main Business and Markets Served
Table Amgen Genetic Disorders Drug Production Sites and Area Served
Table Amgen Genetic Disorders Drug Specification and Application
Table Amgen Genetic Disorders Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Amgen Genetic Disorders Drug Sales Growth Rate (2014-2019)
Figure Amgen Genetic Disorders Drug Revenue Share in International Market (2014-2019)
Figure Amgen Genetic Disorders Drug Main Business and Markets Served
Table GW Pharmaceuticals Genetic Disorders Drug Production Sites and Area Served
Table GW Pharmaceuticals Genetic Disorders Drug Specification and Application
Table GW Pharmaceuticals Genetic Disorders Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure GW Pharmaceuticals Genetic Disorders Drug Sales Growth Rate (2014-2019)
Figure GW Pharmaceuticals Genetic Disorders Drug Revenue Share in International Market (2014-2019)
Figure GW Pharmaceuticals Genetic Disorders Drug Main Business and Markets Served
Table Pfizer Genetic Disorders Drug Production Sites and Area Served
Table Pfizer Genetic Disorders Drug Specification and Application
Table Pfizer Genetic Disorders Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Pfizer Genetic Disorders Drug Sales Growth Rate (2014-2019)
Figure Pfizer Genetic Disorders Drug Revenue Share in International Market (2014-2019)
Figure Pfizer Genetic Disorders Drug Main Business and Markets Served
Table BioMarin Genetic Disorders Drug Production Sites and Area Served
Table BioMarin Genetic Disorders Drug Specification and Application
Table BioMarin Genetic Disorders Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure BioMarin Genetic Disorders Drug Sales Growth Rate (2014-2019)
Figure BioMarin Genetic Disorders Drug Revenue Share in International Market (2014-2019)
Figure BioMarin Genetic Disorders Drug Main Business and Markets Served
Table Sarepta Genetic Disorders Drug Production Sites and Area Served
Table Sarepta Genetic Disorders Drug Specification and Application
Table Sarepta Genetic Disorders Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Sarepta Genetic Disorders Drug Sales Growth Rate (2014-2019)
Figure Sarepta Genetic Disorders Drug Revenue Share in International Market (2014-2019)
Figure Sarepta Genetic Disorders Drug Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Key Raw Materials Price Trend
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Genetic Disorders Drug
Figure Manufacturing Process Analysis of Genetic Disorders Drug
Figure Genetic Disorders Drug Industrial Chain Analysis
Table Genetic Disorders Drug Distributors List
Table Genetic Disorders Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Genetic Disorders Drug Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Global Genetic Disorders Drug Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Genetic Disorders Drug Price (USD/Unit) and Trend Forecast (2019-2025)
Table Global Genetic Disorders Drug Sales (K Units) Forecast by Regions (2019-2025)
Figure Global Genetic Disorders Drug Sales Market Share Forecast by Regions (2019-2025)
Figure Global Genetic Disorders Drug Sales Market Share Forecast by Regions in 2025
Table Global Genetic Disorders Drug Revenue (Million USD) Forecast by Regions (2019-2025)
Figure Global Genetic Disorders Drug Revenue Market Share Forecast by Regions (2019-2025)
Figure Global Genetic Disorders Drug Revenue Market Share Forecast by Regions in 2025
Figure United States Genetic Disorders Drug Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure United States Genetic Disorders Drug Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Genetic Disorders Drug Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Europe Genetic Disorders Drug Revenue and Growth Rate Forecast (2019-2025)
Figure China Genetic Disorders Drug Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure China Genetic Disorders Drug Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Genetic Disorders Drug Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Japan Genetic Disorders Drug Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Genetic Disorders Drug Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Genetic Disorders Drug Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure India Genetic Disorders Drug Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure India Genetic Disorders Drug Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Genetic Disorders Drug Sales (K Units) Forecast by Type (2019-2025)
Figure Global Genetic Disorders Drug Sales Market Share Forecast by Type (2019-2025)
Table Global Genetic Disorders Drug Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Genetic Disorders Drug Revenue Market Share Forecast by Type (2019-2025)
Table Global Genetic Disorders Drug Price (USD/Unit) Forecast by Type (2019-2025)
Table Global Genetic Disorders Drug Sales (K Units) Forecast by Application (2019-2025)
Figure Global Genetic Disorders Drug Sales Market Share Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources